Blueprint Medicines signs deals for up to $1.25B in cash, earnouts

Blueprint Medicines Corp. has struck deals with Sixth Street and Royalty Pharma plc to bring in up to $1.25 billion.

Source: bizjournals.com Health Care:Biotechnology headlines - June 30, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news